N/A N=106 The Role of Apathy in Glycemic Control
Apathy · Diabetes
Primary: Change in HbA1c Over Baseline — -1.0; -0.1 percentage of HbA1c
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=101 Role of Apathy in the Effectiveness of Weight Loss Interventions
Obesity · Apathy
Primary: Apathy Evaluation Scale — -7.69; -6.4; -6.15 units on a scale
Phase 2 N=60 Apathy in Dementia Methylphenidate Trial (ADMET)
Apathy · Alzheimer's Disease
Primary: Apathy Evaluation Scale (AES) — -1.9; 0.6 units on a scale
Phase 4 N=60 Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Alzheimer's Disease · Apathy · Dementia
Primary: Apathy Evaluation Scale Score at 12 Weeks — 38.2; 43.6 units on a scale — p=<0.05
Phase 3 N=200 Apathy in Dementia Methylphenidate Trial 2
Apathy · Alzheimer's Disease
Primary: Neuropsychiatric Inventory (NPI) — -4.5; -3.1 score on a scale
Phase 3 N=22 Treatment of Apathy in Alzheimer's Disease With Modafinil
Apathy · Alzheimer's Disease
Primary: Apathy — 88.91; 95.64 T-score — p=0.181
N/A N=24 Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease
Parkinson's Disease
Primary: Apathy Evaluation Scale (AES) — 19.6; 18.8; 17.9; 16.8 units on a scale
Phase 4 N=483 A Study of Patients With Major Depressive Disorder and Residual Apathy
Major Depressive Disorder
Primary: Change From Baseline in the Apathy Evaluation Scale - Clinician Rated Version (AES-C) Total Score at Week 8 — -13.88; -13.50 units on a scale — p=0.612
Phase 4 N=122 Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy
Idiopathic Parkinson's Disease
Primary: Change From Baseline to the End of the Maintenance Period in the Score of the Apathy Evaluation Scale (AS) Rated by the Patient — -4.4; -4.6; -4.9 scores on a scale…